Elizabeth Sharpe
Ophthalmology · Mt Pleasant, SCNPI 1316903214
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 24.2% of the total. Reporting peaked in 2019 at $941 and has fallen 75.9% since, to $226 in 2025.
Across 80 payments — averaging $37.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$729
- Aerie Pharmaceuticals, Inc.$506
- Bausch & Lomb, A Division Of Bausch Health US, LLC$380
- Alcon$335
- Glaukos Corporation$299
- Bausch & Lomb Americas Inc.$258
- plus $511 from 9 others
Across 56 payments — averaging $2757.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$154K
What the payments were for
- Food & beverage$2,93797%
- Education$140%
- Other$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $729 |
| Aerie Pharmaceuticals, Inc. | 8 | $506 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $380 |
| Alcon | 7 | $335 |
| Glaukos Corporation | 6 | $299 |
| Bausch & Lomb Americas Inc. | 5 | $258 |
| NEW World Medical,inc. | 4 | $168 |
| Novartis | 1 | $124 |
| Akorn, Inc. | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Akorn Operating Company LLC | 2 | $32 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $26 |
| Ivantis, Inc | 1 | $19 |
| Sight Sciences, Inc. | 1 | $15 |
| Ocular Therapeutix, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rhopressa$346
- Rocklatan$346
- Hydrus Microstent$149
- XIIDRA$124
- DURYSTA$101
How this compares
$3,018 in reported general payments places this provider in the 60th percentile of 293 ophthalmology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $172 |
| Latanoprost | 14 | $149 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Mt Pleasant
- Kerry SolomonMt Pleasant$1.7M
- George WaringMt Pleasant$645K
- Erik HappMt Pleasant$124K
- William ClarkWest Columbia$768K
- Karolinne RochaCharleston$552K
- Joseph BishopHilton Head Island$136K
- Matthew ClaryColumbia$119K
- Kunal KanitkarLexington$83K
- Carl SloanMyrtle Beach$78K
- David VromanLadson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.